Biosimilars Council

Mission:
The Biosimilars Council works to increase patient access to lifesaving, affordable biosimilar medicines. Leveraging their deep relationships on Capitol Hill, in federal agencies like FDA and CMS, and in the states, they strive to create a positive regulatory, reimbursement, political and policy environment to assure biosimilars thrive, providing billions in savings to patients and the health care system. Their members include biosimilar manufacturers and stakeholders working to promote biosimilar products in the U.S. market.

The Biosimilars Council is a division of the Association for Accessible Medicines, an organization dedicated to improving access to safe, quality, effective medicine.

“Biosimilars hold the key to ensuring affordable access to biologic-alternatives medicines for all consumers. They exist to educate, advocate, and promote the development of these products.”